This book brings together the behavioral, physiological, and neuroendocrine regulation of calcium. An understanding of how the brain orchestrates whole-body demands for calcium is introduced. The approach is one in which behavior in addition to physiology serves bodily maintenance. The book links basic and clinical literature surrounding calcium homeostasis, as a wide variety of clinical syndromes are tied to calcium metabolism. Because calcium is so important during life stages particular to women, an emphasis is placed on the relevance of calcium to women's health throughout the book, though not exclusively since calcium is fundamental to both sexes.

This book brings together the behavioral, physiological, and neuroendocrine regulation of calcium. An understanding of how the brain orchestrates whole-body demands for calcium is introduced. The approach is one in which behavior in addition to physiology serves bodily maintenance. The book links basic and clinical literature surrounding calcium homeostasis, as a wide variety of clinical syndromes are tied to calcium metabolism. Because calcium is so important during life stages particular to women, an emphasis is placed on the relevance of calcium to women's health throughout the book, though not exclusively since calcium is fundamental to both sexes.

The aim of this book is to provide the target audience, specifically students of Medicine, Biology, Systems Biology and Bioinformatics, as well as experienced researchers in research fields relevant to metabolic syndrome (MetS) with an overview of the challenges and opportunities in systems biology and how it can be used to tackle MetS. In particular, the aims are: (1) to provide an introduction to the key biological processes involved in the pathophysiology of MetS; (2) through the use of specific examples, provide an introduction to the latest technologies that use a systems biology approach to study MetS; and (3) to give an overview of the mathematical modeling approaches for studying MetS.

The clearly written chapters by leading experts in the field provides detailed descriptions crucial for the unique position of this book and its focus on the application of systems biology to tackle specific pathophysiologically relevant aspects of MetS and provides a valuable practical guide to this research community.

"

Auf die Bedurfnisse der taglichen Praxis abgestimmt
Strukturierte, klar definierte Vorgehensweisen fur Diagnostik, Therapiekonzepte und personalisierte Therapieziele.

Umfassende Information, inklusive
- Pravention, Fruherkennung
- Begleiterkrankungen: Fettstoffwechselstorungen, Hypertonie ...
- Folgeerkrankungen: Gefasserkrankungen, Nephropathie, Neuropathien ...
- Patientenschulung: Ernahrung, Lebensfuhrung ...
Besonderheiten bei
- Kindern/Jugendlichen, Schwangeren, alten Patienten
- perioperativer Betreuung, enteraler und parenteraler Ernahrung
- psychiatrischen Erkrankungen einschliesslich Demenz
- Sport, Reisen
Komplexe Fragen kompetente Antworten
- Stufentherapie individuell abgestimmt auf Begleiterkrankungen, Bedurfnisse und Moglichkeiten des Patienten
- Praxistipps fur typische und atypische Therapieprobleme
- neue und zukunftige Therapieformen

NEU u.a.
- Bariatrische Chirurgie
- Compliance und Empowerment
- Qualitatssicherung und Versorgungsforschung
- DMPs, DRGs

Nach den Leitlinien/Richtlinien
- Deutsche Diabetes Gesellschaft (DDG)
- Osterreichische Diabetesgesellschaft (ODG)
- Schweizerische Gesellschaft fur Endokrinologie und Diabetologie (SGED)

Interdisziplinar, topaktuell. Von den fuhrenden Experten aus Deutschland, Osterreich, Schweiz.

Wissen fur das optimale Diabetes-Management gerade heute besonders wichtig."

During the last 8-10 years the research on homocysteine has become very active. Hundreds of articles are now published each year. A disturbed homocysteine metabolism can be an underlying factor for pregnancy complications and fetal malformations, cardiovascular disease, dementia, psychiatric and neurologic disorders and possibly carcinogenesis. A disturbed homocysteine metabolism can in most cases be normalized by treatment with folate and/or vitamines B12 and B6. Many of these findings therefore directly concern most practitioners.

Fabry disease is an X-linked inborn error of metabolism wherein deficiency of a lysosomal enzyme results in systemic deposition of glycosphingolipids. Storage deposition, and hence pathological disease, occurs preferentially in renal glomerular and tubular epithelial cells, myocardial cells, heart valve fibrocytes, neurons of dorsal root ganglia, and in endothelial smooth muscle cells of blood vessels. Thus, Fabry disease is a multi-system disorder, albeit with considerable phenotypic heterogeneity in onset and in severity; however, it is progressive, exhibits extensive morbidity, and is life-threatening. Within the past two decades, there has been a radical change in the natural course Fabry disease by virtue of the availability of specific enzyme replacement therapy. Moreover, there has been a concerted effort to better understand the underlying pathology and equally to identify patients prior to the onset of irreversible end-organ damage. It is to be hoped that the future for patients with Fabry disease can be viewed with greater, albeit guarded, optimism. This state-of-the-art textbook attempts to bridge the span of pre-clinical studies, clinical finding, and management options in a readable but comprehensive manner for the medical practitioner as well as the interested non-medical reader.

Fatigue; weight gain; depression; arthritis; high cholestrol; low sex drive; skin, digestive, and female problems; abnormal blood pressure -- all may be symptoms of low thyroid, one of the most misdiagnosed disorders in America.

Thyroid Power can help you determine whether you're one of the millions who suffer from low thyroid. It discusses food, vitamins, and natural remedies that support thyroid health;explains how to avoid environmental and emotional triggers; and offers tips from thyroid support groups. By following this clear 10-step program and working with your health practitioner, you can channel the incredible power of your thyroid into greater health and well-being.

Contents:
Part 1. Insulin Signaling 1. Overview: Tyrosine Kinase Signaling in Insulin Action Martin G, Meyers, Jr. 2. Defects in Early Insulin Signaling in Skeletal Muscle M. Dodon Michel and C. Ronald Kahn 3. Defects in Intermediate Insulin Signaling in Skeletal Muscle: (PI) 3-kinase and Glucose Transport Francesco Giorgino Part 2. Glucose Transport 4. Glucose Transport in Muscle John O. Hollozsy and Lorrine A. Nolte 5. The GLUT4 Compartments of Skeletal Muscle Toolsie Ramlal, Peter Tong, Tony Lam, Romel Somwar, Maureen Charron and Amira Klip Part 3. Substrate Utilization 6. Adverse Metabolic Consequences of Hyperglycemia ('Glucose Toxicity'): Implications for the Pathogenesis of Diabetes Mellitus Donald A. McClain 7. Cellular Mediators of Glucose-Induced Autoregulation of Hexose Transport Evgenia Alpert, Hanan Totrie and Shlomo Sasson 8. Physiological Adaptations in Glucose Utilization of Skeletal Muscle Julian M.R. Mathoo and Mladen Vranic 9. Fatty Acids and Muscle Insulin Resistance Edward W. Kraegen, Gregory J. Cooney, Jiming Ye, Alison L. Thompson and Stuart M. Furler 10. Role of AMP Kinase and Malonyl CoA in Exercise-stimulated Skeletal Muscle Metabolism and Insulin Action David J. Dean and Neil B. Ruderman Part 4. Transgenic and Genetic Models 11. The Use of Mouse Transgenic and Homologous Recombination Technologies to Analyze the Physiologic Basis of Glucose Homeostasis Silvia Mora and Jeffrey E. Pessin 12. Transgenic Approaches to Insulin Signaling Yasuo Terauchi and Takashi Kadowaki 13. Transgenic Models to Study Glucose Transport and Metabolism in Skeletal Muscle Armelle Leturque and Anna-Maria Lombardi Part 5. Diabetic Animals 14. Insulin Resistance in Skeletal Muscle: a Role for Impaired Insulin Activation of Glycogen Synthase Heidi K. Ortmeyer 15. Muscle GLUT4 Traffic and Insulin Resistant States Antonio Zorzano, Eva Tomas, Marta Camps, Anna Guma and Manuel Palacin 16. Glucose Transport in Heart: Special Emphasis on Insulin Resistance and NIDM Jurgen Eckel 17. Cellular Redox State and Insulin Sensitivity: Potential Role of Lipoic Acid Assaf Rudich and Nava Bashan Part 6. Exercise and Aging 18. Exercise Training and Muscle Insulin Resistance: Cellular Adaptations John L. Ivy 19. Effects of Physical Exercise on the Decreased Insulin Action Caused by Aging Yuzo Sato 20. Effects of Aging on Glucose Homeostasis: Cellular Approaches Gregory D. Cartee Part 7. Application to Humans 21. Insulin Resistance: Whole Body Mechanisms in Humans Hannele Yki-Jarvinen 22. Cellular Mechanisms Dana Galuska and Anna Krook

The critically ill patient in intensive care may present with serious metabolic alterations caused directly by the illness or secondarily by complications (e.g. infections, organ failure or sepsis) developing within a few hours of hospitaliza tion or in the following days. Among the situations which maintain and further trigger rapidly evolving altered metabolism are complex hormonal reactions, particularly those of the hypothalamus-hypophysis-adrenal axis, and abnormal stimulation of the autonomic nervous system. In fact, the sympathetic nervous system is known to cause significant metabolic alterations. For example, a surgery patient afflicted by septic complications may become hypercatabolic and experience significant nitrogen loss; the altered protein metabolism may in turn heavily influence carbohydrate and lipid metabolism as well. Thus, it is apparent that for optimal care of patients with altered metabolic functions, further knowledge is necessary regarding the physiopathology of metabolism and the physiopathological mechanisms, which alter the consump tion of principal energy substrates. Many experimental and clinical studies have investigated the metabolic aspects of individual organs or organ systems. However, for a correct evaluation of such metabolic events, in addition to studying the roles of metabolic enzymes, active metabolites, and the glutathione system, it is interesting to consider the use of indirect calorimetry as a valid and important investigative technique. The critically ill patient with major alterations in nutritional status may require artificial nutritive support administered through either parenteral or enteral routes."

Take control of your weight--and your diabetes. Managing your weight is critical when you have diabetes. In fact, losing as little as 10 to 20 pounds can improve diabetes control. With this innovative book, you can manage your weight and your diabetes by making gradual lifestyle changes you'll be able to live with for the rest of your life--like following a low-fat meal plan, becoming more active, and managing stress. Weight Management for Type II Diabetes will help you assess habits, teach you techniques of behavior change, and motivate you to find the support you need to manage both diabetes and your weight. This interactive guide takes you through the steps of developing a personalized plan that considers your lifestyle, personality, family situation, and wants and needs. Authors Jackie Labat, MS, RD, CDE, and Annette Maggi, MS, RD, will help you:
* Set reasonable goals
* Keep pace with an exercise program
* Design your own meal plan
* Handle special occasions
* Manage stress
* Learn to deal with lapses
The book also provides fat and calorie counts, grocery shopping tips, and a lesson in low-fat cooking.

As an endocrinologist and research scientist--and a diabetic for over 29 years--Dr. Joseph Juliano has devoted his life to understanding the disease. Now, he shows the millions of Type I, insulin-dependent diabetes sufferers how to avoid complications and overcome them if they occur, empowering readers with the motivation and information to control their disease.

1. 1 Scientific Aims In recent years, there has been a definite trend away from the casuistic scientific thinking which has dominated the scientific world, at least in the field of medicobi ological research. Now, in the last decade of this century, scientists are returning to a conceptual way of thinking that characterized the beginning of this century, namely organismal thinking. The holistic concept is not a new one; it was rekindled by a small group of scientists who, in the previous two decades, have begun to warn against too great an emphasis being placed on a molecular casuistic approach as the final pursuit to science (see Duncker 1983). These thinkers were perhaps instrumental in helping to turn the tide, to instruct and encourage fellow researchers to extend their findings from the molecular and to the organismal (see Duncker 1983, 1992a, b; Duncker and Kreite 1987). Having observed the ceca of many different animals for many years and having described their morphology at different levels of study -from the macroscopic to the electron microscopy level - the need to compare and observe these morphological entities in a quantitiative way became increasingly imminent. Quantitative methodol ogy in morphology requires the use of morphometry, which in the most general terms can be described as the measurement of the forms of animals. As defined by Reith and Meyhew (1988), it is quantitative morphology, i. e., the measurement of structures by any method, including stereology."

This introduction to the mechanisms by which the body metabolizes and excretes administered drugs is directed at advanced undergraduate biochemists, pharmacologists, pre-clinical medical strudents and advanced undergraduate/postgraduate toxicologists. The subject is approached from both biochemical and physiological angles. The examples of drug metabolism have been kept clinically relevant, so that the practical importance of the subject can be easily appreciated. The book contains a section of experimental procedures for setting up student practicals in drug metabolism.

Enzymes are the astonishing, tiny molecular machines that make life possible. Each one of these small proteins speeds up a single chemical reaction inside a living organism many millionfold. Working together, teams of enzymes carry out all the processes that collectively we recognise as life, from making DNA to digesting food. This Very Short Introduction explains the why and the how of speeding up these reactions - catalysis - before going on to reveal how we have evolved these catalysts of such extraordinary power and exquisite selectivity. Paul Engel shows how X-ray crystallography has revealed the complex molecular shapes that allow enzymes to function at an extraordinarily sophisticated level. He also examines medical aspects of enzymes, both in the way faulty enzymes cause disease and in the way enzymes can be used for diagnosis and therapy. Finally, he looks at the many varied ways in which individual enzymes, taken out of their biological context, are used nowadays as tools - in washing powders, food production, waste treatment, and chemical synthesis. ABOUT THE SERIES: The Very Short Introductions series from Oxford University Press contains hundreds of titles in almost every subject area. These pocket-sized books are the perfect way to get ahead in a new subject quickly. Our expert authors combine facts, analysis, perspective, new ideas, and enthusiasm to make interesting and challenging topics highly readable.

This book discusses the latest research in the pathophysiology, diagnosis, and screening of diabetes and its management. It reviews novel technologies for early diagnosis and highlights the molecular mechanisms of microvascular and macrovascular complications of diabetes 2 mellitus. The book covers the applications of nanotechnology in diagnostics, monitoring, and treatment of diabetes mellitus. The chapter also presents the latest developments in differentiating pancreatic cells from PSCs and illustrates the challenges of their therapeutic application in treating diabetes. The book also explores the prospective medicinal plants comprising either plant extract or isolated bioactive phytoconstituents bearing anti-diabetic potential, which has been reported in several in vitro, in vivo, or clinical studies. It further examines the major mechanisms involved in cardiovascular complications among type 2 diabetes mellitus individuals and discusses the various pharmacological interventions and agents developed to delay cardiovascular events and thereby the quality and duration of the patients. Towards the end, the book summarizes the potential impact of ketogenic diets on diabetic patients, and the role of genetic vulnerability in diabetic nephropathy. As such, this book is a valuable source for students, researchers, and practitioners working in glucose metabolism, diabetes, and human health.

Although prostaglandin El (PGE ) has been clinically available for a long 1 time, only in recent years has its effectiveness in peripheral arterial occlusive disease been confirmed in controlled studies. Not surprisingly, the favour able results achieved both in patients with critical limb ischaemia and in those with intermittent claudication has stimulated research activities into the clinical pharmacology of this prostaglandin. As a consequence of these efforts, exciting new findings have revealed that PGE has anti thrombotic, endothelium-stabilizing and leucocyte-stabi 1 lizing properties as well as effects on lipid metabolism, all of which, quite apart from its well-known anti-aggregating and vasodilator effects, may add to the clinical efficacy of the substance. New data have also been gathered on the metabolism of PGE most b notably the detection of 13,14-dihydro-PGE a metabolite which was b recently isolated in humans following the administration of PGE . Being 1 biologically active, the pharmacodynamic spectrum of 13,14-dihydro-PGE 1 very closely resembles that of PGE . This finding may help to explain the 1 efficacy of PGE despite its rapid metabolization when given intravenously."

This is an intergated approach to exercise physiology explaining how the major systems are all affected by autonomic neural control during exercise. It considers physiology, energy metabolism, the cardiovascular, respiratory system and temperature regulation.;These areas have been selected for their significance during exercise because of the crucial importance of the autonomic nervous system in their control. In each case resting physiology is described before the derangements caused by exercise are discussed. It also examines some of the factors which affect autonomic nervous activity during exercise, namely age, sex, training and drugs and considers the clinical application of applied physiology.;The book is intended primarily for undergraduate and postgraduate students in sport science with a specialist interest in exercise physiology. It is assumed that the reader will already have studied some physiology and physiology of exercises, and therefore this text is intended to supplement general textbooks and lecture material. Since exercise physiology provides a good example of a disturbance of homeostasis and the subsequent role of physiological control mechanisms to restore equilibrium, it is hoped that this text will also prove useful for students in medical and life sciences.

On November 6 and 7, 1987, lipid and lipoprotein researchers from all over Europe convened in Munich on the occasion of the second European Workshop on Lipid Metabolism (EWLM). This informal gathering was devoted to two main topics, and recent research results were presented and discussed during a poster session. Recent developments in the physiology and pathophysiology of lipoprotein sub fractions were discussed on the first day of the meeting. In recent years, new analytical tools have been created for analyzing lipoprotein subfractions, particularly the apolipoprotein component. With the, introduction of immunological and elec trophoretic methods it has become clear that the heterogeneity of the plasma lipopro tein system is even greater than had been assumed only a decade or so ago. Despite this, it is apparent from the contributions to this volume that new methods for differentiating lipoprotein subfractions will increase our understanding of lipoprotein metabolism, especially of the triglyceride-rich lipoprotein particles and the high density lipoproteins. The complex functions of the various plasma apolipoproteins and their association with the lipoprotein lipid in single or complex lipoprotein particles give rise to a complex and dynamic metabolic system that changes constantly during the day. While it has for some time been possible to delineate fairly accurately the atherogenic potential of low-density lipoproteins, which are comparatively simple lipoprotein particles, the new methods of lipoprotein subfraction analysis will be needed to select and differentiate amongst the potentially atherogenic triglyceride rich particles, especially the chylomicron and very low density lipoprotein remnants.

Ein Screening auf angeborene endokrine und metabole Stoerungen ermoeglicht die Fruherkennung von Krankheiten wie Hypothyreose, AGS (adrenogenitales Syndrom), Phenylketonurie, Galaktosamie, Biotinidasemangel, Cystische Fibrose oder Homocystinurie. Je nach Land und politischen Bestimmungen unterscheiden sich jedoch die routinemassig durchgefuhrten Untersuchungen. Dieses Handbuch beschreibt praxisbezogen die biochemischen Grundlagen, die Grundsatze der Labor- und Bestatigungsdiagnostik sowie Therapiemoeglichkeiten zu insgesamt zwoelf Krankheiten. Daruber hinaus werden praanalytische Fragen, wie Zeitpunkt und Art der Blutentnahme oder moegliche Stoerfaktoren, umfassend behandelt. Der allgemeine Teil geht auf ethische und psychosoziale Aspekte des Screenings ein. Ein Verzeichnis der Screeningzentren und jener Labors, die fur die Bestatigungsdiagnostik Dienste anbieten, sowie ein Adressenverzeichnis von Elterngruppen und Informationsquellen im Internet komplettieren dieses Buch.

A number of clinical and epidemiological studies have shown that disorders of lipoprotein metabolism constitute one of the most important risk factors for the development of atherosclerosis and coronary heart disease. This volume examines the state of the art of lipoprotein subclass metabolism and its relation to these diseases. The authors also report on new developments concerning the role of lipoprotein recptors, macrophages and apolipoprotein E polymorphism in cholesterol homeostasis. The combination of general outline form and very specific aspects of cholesterol transport will interest those in other disciplines following developments in the field, as well as those directly involved in lipoprotein research.

Initiated in 1975, the Eberbach/Wiesloch Study is a prospective preventive study modeled after the Cardiovascular Comprehensive Community Central Programme of the WHO, with the aim of lowering the incidence of cardiac infarctions in a population representative of that of the Federal Republic of Germany. Part of the study is devoted to a description of smoking habits, and in particular, of the effect of cigarette smoking on plasma lipid and lipoprotein levels. Important components of this investigation were the inclusion of plasma levels of cotinine (a stable metabolite of nicotine and the only precise parameter of cigarette consumption), as well as the correlation of cotinine with other plasma parameters. Not only are these studies unique in the Federal Republic of Germany, but they also provide significant insight into the development of arteriosclerosis in connection with the established risk factors of smoking and hyperlipidemia. The data collected point to a considerable influence of smoking behavior on plasma lipid protein parameters.